Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein helps immune system mount ’instant strike’ against deadly flu viruses

19.02.2004


Discovery suggests that a ’live virus’ vaccine may offer best defense against avian flu

Researchers at the University of Rochester have identified a protein in the immune system that appears to play a crucial role in protecting against deadly forms of influenza, and may be particularly important in protecting against emerging flu viruses like the avian flu. The researchers believe that a vaccine made with a live but weakened strain of flu virus – such as the inhaled flu vaccine introduced last year – may activate this part of the immune system and offer the best defense against avian flu.

In a paper being published in the February 20 issue of Immunity, the researchers report that a protein called VLA-1 enables the immune system to develop "peripheral immunity" by anchoring millions of virus-killing cells to tissues along the airways and lungs, where flu enters the body. The protein holds the cells in place and helps them survive there for long periods – sometimes years – where they stand ready to mount an immediate attack on the flu virus.



In a series of experiments, mice whose T cells were able to make the protein were able to develop peripheral immunity, and 90 percent of them survived after being infected with a potentially deadly strain of flu. Mice with T-cells engineered to lack the protein failed to develop peripheral immunity, and only 60 percent of them survived after being infected with the same flu virus.

The findings demonstrate that when confronted by a potentially deadly flu strain, an effective first strike by T cells in the lungs can mean the difference between life and death. To immunologist David Topham, Ph.D., assistant professor of Microbiology and Immunology at the University of Rochester and lead author of the study, the findings reveal something else: a shortcoming in the world’s most widely administered flu vaccines. Those vaccines, made with fragments of "killed" viruses, help the immune system make antibodies against the flu virus but do not induce peripheral immunity.

The trouble with antibodies, says Topham, arises when a flu virus changes, either by mutating or by swapping genes with another virus – a scenario that experts fear would lead to a pandemic of avian flu. When a virus changes, antibodies often have difficulty recognizing the new virus and mobilizing the immune system to attack. And even if they do, it takes two to three days for antibodies to stimulate the production of T cells, and for those cells to begin attacking the virus. Unlike antibodies, T cells are much more effective at recognizing viruses that have changed, and they can attack instantly.

"In a lethal form of flu, like avian flu has the potential to be, you may not have three days. A lethal infection can gain such a foothold in that time that it can become very difficult or impossible for the immune system to overcome it," said Topham.

Topham believes that to protect people against an outbreak of avian flu, vaccine developers should switch to a vaccine made with a live but weakened flu virus. Such vaccines are thought to more closely mimic a natural encounter with the flu virus and are more likely to induce peripheral immunity, which might deliver an instant strike against the virus as the infection begins.

"When confronted by a deadly flu virus, the ability to attack it instantly, as soon as the virus hits the lungs, might mean the difference between life and death," said Topham. "Our goal should be to design a vaccine that helps the immune system produce peripheral immunity. A vaccine made from live virus offers the best chance of accomplishing this."


The research was funded by the National Institutes of Health, and conducted at the David H. Smith Center for Vaccine Biology, part of the Aab Institute of Biomedical Sciences at the University of Rochester Medical Center.

Chris DiFrancesco | EurekAlert!
Further information:
http://www.urmc.rochester.edu/

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Silicon solar cell of ISFH yields 25% efficiency with passivating POLO contacts

08.12.2016 | Power and Electrical Engineering

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>